Arkolith/Insider Trading/CGON/Form 4

Mulay James

DirectorCG Oncology, Inc. (CGON) · full profile →Form 4 · filed Apr 20, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.1M
Net Open-Market Flow
-$1.1M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 17, 2026Option exercise(M)16K$36.63$571K16K
Apr 17, 2026Sell(S)16K$73.01$1.1M0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 17, 2026Option exercise(M)16K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-164013) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML